Interactions of pDCs with Aspergilus
Interactions of pDCs with Aspergilus
批准号:
8789386
负责人:
Stuart Michael Levitz
金额:
$41.25万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2016-01-31
关键词:
Acute DiseaseAddressAllergicAnimal ModelAntifungal AgentsApoptosisAspergillosisAspergillus fumigatusAutoimmune DiseasesBacteriaBiologyCD8B1 geneCellsCessation of lifeChelating AgentsChronicDataDendritic CellsDiagnosticEarly treatmentEnvironmentFlow CytometryFundingFungal Drug ResistanceGliotoxinGrowthHealthHost DefenseHumanHyphaeImmuneImmune responseImmune systemImmunocompromised HostImmunologyImmunosuppressive AgentsIn VitroIncubatedInfectionInflammatory ResponseInterferon Type IInterferonsIntravenousKnockout MiceKnowledgeLeadLeukocyte L1 Antigen ComplexLeukocytesLifeLinkLungMaintenanceMediatingMicroscopyModelingMoldsMorbidity - disease rateMusMycosesMycotoxinsNatural Killer CellsNecrosisNeoplasmsNeutropeniaNucleic AcidsPathogenesisPathologyPatientsPattern recognition receptorPersonsPlayPopulationPreventionPulmonary InflammationRoleT-LymphocyteTLR7 geneTNF geneViralVirusZincadaptive immunityarmbasecell typechemokinecytokinedefined contributionfollow-upfungusin vivoin vivo Modelmacrophagemonocytemortalityneutrophilnovel strategiespathogenperipheral bloodpreventreceptorresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Aspergillus fumigatus is the most common cause of invasive mold infections. Even with advances in therapy and early diagnostics, mortality rates remain high. Plasmacytoid dendritic cells (pDCs) comprise a functionally distinct lineage of DCs that rapidly produce copious amounts of type I interferons (IFNs) upon stimulation with viruses, predominantly via mechanisms dependent on sensing of viral nucleic acids. pDCs link innate to adaptive immunity by secreting cytokines and by priming T cells. The interplay between pDCs and fungi has not been well characterized. The application builds upon compelling preliminary data demonstrating that: 1) human pDCs directly inhibit fungal growth via a mechanism that involves A. fumigatus-induced pDC death; 2) following stimulation with A. fumigatus hyphae, pDCs release cytokines, including type I IFNs; 3) depletion of pDCs renders mice hypersusceptible to pulmonary and intravenous challenge with A. fumigatus by a mechanism that appears to be due, at least in part, to a dysregulated immune response; and 4) pulmonary infection with A. fumigatus results in pDC influx into the lungs. We hypothesize that pDCs play a major role in host defenses against invasive aspergillosis by mediating direct antifungal activity and by modulating the innate and adaptive immune response. To address this hypothesis, we will define the contribution of pDCs in the defense against A. fumigatus using both in vitro and in
vivo models. In Aim 1, we will explore the mechanistic basis of our observations that incubation of pDCs with A. fumigatus in vitro results in fungal recognition, antifungal activity and cytokine release. The receptors required for pDC recognition of the conidial and hyphal fungal morphotypes will be explored. The mechanism of pDC death induced by A. fumigatus will be elucidated. How pDCs mediate antifungal activity will be characterized using both intact pDCs and pDC lysates. Finally, the cytokine and chemokine response of pDCs to A. fumigatus will be investigated. In aim 2, we will follow up our demonstration that pDCs have a non- redundant role in host defenses against aspergillosis by illuminating the mechanisms by which this occurs. The effect of pDC depletion on mortality, fungal burden, immune cell recruitment, pathology and cytokine response will be determined in murine models of invasive aspergillosis. The arms of the immune system required for pDC-mediated protection will be examined by co-depleting pDCs and specific leukocyte subsets and with knockout mice. Lastly, we will determine whether pDCs associate with conidia and hyphae in vivo using flow cytometry and microscopy. Completion of these studies over the funding period will result in major conceptual advances in fungal pathogenesis, fungal immunology and pDC biology. Moreover, the knowledge gained may lead to novel strategies to prevent and treat invasive mycoses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A subunit Cryptococcus vaccine
-
批准号:10539210
-
项目类别:
-
资助金额:$61.98万
-
财政年份:2022
-
负责人:Stuart Michael Levitz
-
依托单位:
A subunit Cryptococcus vaccine
-
批准号:10669795
-
项目类别:
-
资助金额:$61.98万
-
财政年份:2022
-
负责人:Stuart Michael Levitz
-
依托单位:
The contribution of eosinophils and the IL-23/IL-17 axis to host responses to Aspergillus
-
批准号:10163121
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2018
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:10259153
-
项目类别:
-
资助金额:$79.9万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:10557083
-
项目类别:
-
资助金额:$79.31万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:10598929
-
项目类别:
-
资助金额:$75.38万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:9140479
-
项目类别:
-
资助金额:$65.75万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:9222705
-
项目类别:
-
资助金额:$64.43万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Immune Response to Cryptococcal Infections
-
批准号:8963535
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2015
-
负责人:Stuart Michael Levitz
-
依托单位:
Immune Response to Cryptococcal Infections
-
批准号:9264958
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2015
-
负责人:Stuart Michael Levitz
-
依托单位:
Interactions of pDCs with Aspergilus
-
批准号:8605547
-
项目类别:
-
资助金额:$40.83万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
Glucan Particles as a Vaccine Platform for Protective Immunity
-
批准号:8537625
-
项目类别:
-
资助金额:$52.45万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
2013 Immunology of Fungal Infections GRC and GRS
-
批准号:8451034
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
Glucan Particles as a Vaccine Platform for Protective Immunity
-
批准号:8890767
-
项目类别:
-
资助金额:$54.16万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
Glucan Particles as a Vaccine Platform for Protective Immunity
-
批准号:8715685
-
项目类别:
-
资助金额:$54.22万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
Interactions of pDCs with Aspergilus
-
批准号:8463798
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
2011 Immunology of Fungal Infections Gordon Research Conference
-
批准号:8057722
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2011
-
负责人:Stuart Michael Levitz
-
依托单位:
Immunostimulatory properties of chitin and chitosan
-
批准号:8320083
-
项目类别:
-
资助金额:$20.56万
-
财政年份:2011
-
负责人:Stuart Michael Levitz
-
依托单位:
Immunostimulatory properties of chitin and chitosan
-
批准号:8071667
-
项目类别:
-
资助金额:$24.68万
-
财政年份:2011
-
负责人:Stuart Michael Levitz
-
依托单位:
Model Vaccines Exploiting Fungal Mannosylation
-
批准号:7082067
-
项目类别:
-
资助金额:$8.77万
-
财政年份:2005
-
负责人:Stuart Michael Levitz
-
依托单位:
海外基金